Mechanisms of mitochondrial toxicity of the kinase inhibitors ponatinib, regorafenib and sorafenib in human hepatic HepG2 cells
Author:
Funder
Swiss National Science foundation
Publisher
Elsevier BV
Subject
Toxicology
Reference47 articles.
1. Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors;Breccia;Leuk. Res.,2013
2. Mechanistic insights into selective killing of OXPHOS-dependent cancer cells by arctigenin;Brecht;Toxicol. In Vitro,2017
3. Manganese superoxide dismutase and oxidative stress modulation;Bresciani;Adv. Clin. Chem.,2015
4. Sorafenib-induced mitochondrial complex I inactivation and cell death in human neuroblastoma cells;Bull;J. Proteome Res.,2012
5. Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy;Chen;Autophagy,2016
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of the role of NLRP3 inflammasome activation in new-generation BCR-ABL1 tyrosine kinase inhibitors-induced hepatotoxicity;Toxicology Letters;2024-10
2. Investigating the interplay between mitophagy and diabetic neuropathy: Uncovering the hidden secrets of the disease pathology;Pharmacological Research;2024-10
3. Underlying mechanisms and management strategies for regorafenib-induced toxicity in hepatocellular carcinoma;Expert Opinion on Drug Metabolism & Toxicology;2024-09-03
4. Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway;Biomedicine & Pharmacotherapy;2024-09
5. Fasting in combination with the cocktail Sorafenib:Metformin blunts cellular plasticity and promotes liver cancer cell death via poly-metabolic exhaustion;Cellular Oncology;2024-07-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3